Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still waiting to see whether AI can tackle their biggest challenge: finding faster, cheaper ways to develop new drugs. Despite billions poured into research and development, new medicines still typically take a decade or more to develop. Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets that could lead to new medicines.